% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Yang:285584,
      author       = {K. Yang$^*$ and D. Doege$^*$ and M. S. Y. Thong$^*$ and L.
                      Koch-Gallenkamp$^*$ and L. Weisser$^*$ and H. Bertram and A.
                      Eberle and B. Holleczek and A. Nennecke and A. Waldmann and
                      S. R. Zeissig and R. Pritzkuleit and L. Jansen$^*$ and H.
                      Brenner$^*$ and V. Arndt$^*$},
      title        = {{D}iabetes mellitus in long-term survivors with colorectal,
                      breast, or prostate cancer: {P}revalence and prognosis. {A}
                      population-based study.},
      journal      = {Cancer},
      volume       = {130},
      number       = {7},
      issn         = {0008-543X},
      address      = {New York, NY},
      publisher    = {Wiley-Liss},
      reportid     = {DKFZ-2023-02446},
      pages        = {1158-1170},
      year         = {2024},
      note         = {#EA:C071#LA:C071# / 2024 Apr 1;130(7):1158-1170},
      abstract     = {Patients with cancer are at increased risk of diabetes
                      mellitus (DM). Previous studies on the prevalence and
                      prognostic impact of DM in cancer survivors were limited by
                      small sample sizes or short follow-up times. We aimed to
                      compare the patient-reported prevalence of DM in long-term
                      cancer survivors (LTCS), who survived 5 years or more after
                      cancer diagnosis, with that in cancer-free controls, and to
                      estimate the mortality risk among LTCS according to DM
                      status.Our population-based cohort comprised 6952 LTCS
                      diagnosed with breast, colorectal, or prostate cancer
                      between 1994 and 2004, recruited in 2008-2011 (baseline),
                      and followed until 2019. A total of 1828 cancer-free
                      individuals served as controls. Multivariable logistic
                      regression was used to compare the prevalence of DM in LTCS
                      and controls, and according to covariates at baseline.
                      Mortality among LTCS according to DM was assessed by Cox
                      proportional hazards regression.A total of 962 $(13.8\%)$
                      LTCS at baseline reported DM. Prevalence of DM in LTCS was
                      not higher than in cancer-free controls, both at baseline
                      (odds ratio, 0.80; $95\%$ CI, 0.66-0.97) and at follow-up
                      (odds ratio, 0.83; $95\%$ CI, 0.67-1.04). Prevalence of DM
                      in LTCS was associated with cancer site, older age, lower
                      education, higher socioeconomic deprivation, higher body
                      mass index, physical inactivity, other comorbidities, and
                      poorer prognosis (adjusted hazard ratio [all-cause
                      mortality] = 1.29; $95\%$ CI, 1.15-1.44).DM in LTCS is
                      prevalent, but not higher than in cancer-free population
                      controls. Cancer survivors with concurrent DM are at a
                      potentially higher risk of death.Cancer and diabetes
                      mellitus (DM) are two serious threats to global health. In
                      our study, prevalence of DM in long-term cancer survivors
                      who survived 5 years or more after cancer diagnosis was not
                      higher than in cancer-free controls. This should not be
                      interpreted as an indication of a lower risk of DM in cancer
                      survivors. Rather, it highlights the potentially poor
                      prognosis in diabetic cancer survivors. Therefore, keeping a
                      continuous satisfactory DM and hyperglycemia management is
                      essential during long-term cancer survivorship.},
      keywords     = {cancer survivors (Other) / control group (Other) / diabetes
                      mellitus (Other) / mortality (Other) / prevalence (Other)},
      cin          = {C071 / C070 / C120 / HD01},
      ddc          = {610},
      cid          = {I:(DE-He78)C071-20160331 / I:(DE-He78)C070-20160331 /
                      I:(DE-He78)C120-20160331 / I:(DE-He78)HD01-20160331},
      pnm          = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
      pid          = {G:(DE-HGF)POF4-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:37996981},
      doi          = {DOI:10.1002/cncr.35133},
      url          = {https://inrepo02.dkfz.de/record/285584},
}